We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+5.29%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$2.55B
AUM Growth
+$104M
Cap. Flow
-$12.9M
Cap. Flow %
-0.51%
Top 10 Hldgs %
23.75%
Holding
502
New
34
Increased
125
Reduced
185
Closed
15

Sector Composition

Rank Sector Weight
1 Healthcare 15.32%
2 Financials 12.89%
3 Consumer Staples 11.67%
4 Industrials 11.53%
5 Technology 11.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASML icon
26
ASML
ASML
$634B
$23.6M 0.92%
177,622
-2,013
-1% -$248K
MRK icon
27
Merck
MRK
$321B
$23.4M 0.92%
386,229
+8,061
+2% +$489K
KO icon
28
Coca-Cola
KO
$381B
$23.4M 0.92%
550,533
-15,248
-3% -$636K
MDLZ icon
29
Mondelez International
MDLZ
$80.5B
$22.2M 0.87%
514,198
-120
-0% -$5.32K
MMM icon
30
3M
MMM
$90.8B
$21.8M 0.85%
136,177
+2,260
+2% +$347K
VZ icon
31
Verizon
VZ
$193B
$21.6M 0.85%
442,814
+127
+0% +$6.37K
ABT icon
32
Abbott
ABT
$183B
$21.1M 0.83%
474,112
+12,130
+3% +$524K
WFC icon
33
Wells Fargo
WFC
$258B
$20.7M 0.81%
371,888
-16,180
-4% -$918K
META icon
34
Meta Platforms (Facebook)
META
$1.37T
$20.5M 0.8%
144,381
-970
-0.7% -$130K
DD
35
DELISTED
Du Pont De Nemours E I
DD
$20.2M 0.79%
251,427
-2,040
-0.8% -$158K
MET icon
36
MetLife
MET
$62.5B
$20.1M 0.79%
426,373
-15,763
-4% -$751K
BRK.B icon
37
Berkshire Hathaway Class B
BRK.B
$1.1T
$19.7M 0.77%
118,400
-225
-0.2% -$37.6K
NVS icon
38
Novartis
NVS
$301B
$19.5M 0.76%
292,674
-23,819
-8% -$1.59M
PM icon
39
Philip Morris
PM
$299B
$18.5M 0.73%
164,256
+2,897
+2% +$299K
GILD icon
40
Gilead Sciences
GILD
$163B
$18.5M 0.72%
272,273
-12,368
-4% -$870K
NKE icon
41
Nike
NKE
$62.7B
$17.8M 0.7%
318,569
+83
+0% +$4.59K
MA icon
42
Mastercard
MA
$510B
$17.5M 0.69%
155,942
-2,839
-2% -$311K
AGN
43
DELISTED
Allergan plc
AGN
$17.4M 0.68%
72,876
+2,118
+3% +$493K
GOOGL icon
44
Alphabet (Google) Class A
GOOGL
$4.08T
$17.3M 0.68%
408,300
+3,360
+0.8% +$141K
UN
45
DELISTED
Unilever NV New York Registry Shares
UN
$17.1M 0.67%
343,947
-8,419
-2% -$377K
DHR icon
46
Danaher
DHR
$138B
$16.6M 0.65%
219,388
-834
-0.4% -$62.1K
PFE icon
47
Pfizer
PFE
$142B
$16.6M 0.65%
512,302
-13,876
-3% -$437K
OXY icon
48
Occidental Petroleum
OXY
$55.6B
$16.3M 0.64%
257,674
-17,294
-6% -$1.15M
NXPI icon
49
NXP Semiconductors
NXPI
$61.8B
$16.3M 0.64%
157,208
-5,017
-3% -$507K
C icon
50
Citigroup
C
$222B
$15.9M 0.62%
266,425
+11,254
+4% +$666K

Similar funds

Gofen & Glossberg's Q1 2017 Portfolio in Review

As of Q1 2017, Gofen & Glossberg held 502 positions worth $2.55B, up 4.3% from $2.45B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Gofen & Glossberg's Q1 2017 filing shows 34 new, 125 increased, 185 reduced and 15 closed positions. Its largest new stake was Johnson Controls International: 84,156 shares worth $3.54M. The largest sale was McDonald's, an estimated $6.04M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Staples.

  • Gofen & Glossberg's largest Q1 2017 buy was Johnson Controls International: 84,156 shares worth $3.54M.
  • Gofen & Glossberg added most to OAKTREE CAPITAL GROUP, LLC in Q1 2017, an estimated $3.82M increase.
  • Gofen & Glossberg's biggest Q1 2017 reduction was McDonald's, cutting an estimated $6.04M.
  • Gofen & Glossberg fully exited Sabre in Q1 2017, selling an estimated $1.24M.
  • Gofen & Glossberg's ten largest holdings make up 24% of its $2.55B portfolio in Q1 2017.
  • Gofen & Glossberg opened 34 new positions and closed 15 in Q1 2017.
  • Gofen & Glossberg's portfolio value rose 4.3% quarter-over-quarter to $2.55B.

Based on Gofen & Glossberg's 13F filing for Q1 2017, filed 11 May 2017.